Firefly announces brain wave biomarkers for ADHD subtype diagnosis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD
March 13, 2026 7:55 AM EDTOver 22 million Americans are diagnosed with ADHD yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1
Fireflys AI-powered EEG/ERP technology may help identify which ADHD subtype a patient has potentially complementing subjective symptom checklists with neural signal-based precision
Subtype identification could change the clinical equation: Fireflys platform may help clinicians determine the most appropriate treatment type, inform dosage decisions, and potentially monitor whether an intervention is working
The breakthrough... More
